On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

Central Valley leaders are asking voters to weigh in one of the oldest public policy questions: Which works better, the ...

The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...

The facility will offer inpatient and outpatient services, including long-term stays, detox, individual and group therapy.

California voters are considering whether to roll back some of the criminal justice reforms enacted a decade ago as concerns ...

“This drug takes the first new approach to schizophrenia treatment in decades.” “This approval offers a new alternative to the antipsychotic medications people with schizophrenia have previously been ...

Single-pill combinations of three or more antihypertensive drugs are the way forward to help patients reach lower blood ...

B.C. is facing a toxic drug crisis, however, forcing people into involuntary treatment will cause more harm than good.

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations ...